$30.27
0.01[0.03%]
Last update: 8:34AM Get Real Time Here
Omega Healthcare Invts
(NYSE:OHI)Omega Healthcare Invts Stock (NYSE:OHI), Analyst Ratings, Price Targets, Predictions
Omega Healthcare Investors Inc has a consensus price target of $30.7, established from looking at the 56 latest analyst ratings. The last 3 analyst ratings were released from Truist Securities, Citigroup, and Wells Fargo on April 2, 2024, March 22, 2024, and February 26, 2024. With an average price target of $34 between Truist Securities, Citigroup, and Wells Fargo, there's an implied 12.32% upside for Omega Healthcare Investors Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Citigroup
Wells Fargo
Exane BNP Paribas
Deutsche Bank
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Omega Healthcare Invts
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/02/2024 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 5.72% | Truist Securities | Michael Lewis | $31 → $32 | Maintains | Hold | Get Alert |
| 03/22/2024 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 15.63% | Citigroup | Nicholas Joseph | $32 → $35 | Upgrade | Neutral → Buy | Get Alert |
| 02/26/2024 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 15.63% | Wells Fargo | Connor Siversky | $31 → $35 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/08/2024 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | -0.89% | Exane BNP Paribas | Nate Crossett | → $30 | Upgrade | Underperform → Neutral | Get Alert |
| 01/30/2024 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 18.93% | Deutsche Bank | Omotayo Okusanya | → $36 | Initiates | → Buy | Get Alert |
| 01/16/2024 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 2.41% | B of A Securities | Joshua Dennerlein | $33 → $31 | Downgrade | Buy → Neutral | Get Alert |
| 01/03/2024 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 12.32% | Mizuho | Haendel St. Juste | $35 → $34 | Maintains | Buy | Get Alert |
| 12/26/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 2.41% | Truist Securities | Michael Lewis | $34 → $31 | Maintains | Hold | Get Alert |
| 11/27/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 9.02% | Wells Fargo | Connor Siversky | $34 → $33 | Maintains | Equal-Weight | Get Alert |
| 11/06/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | — | Exane BNP Paribas | Nate Crossett | — | Downgrade | Neutral → Underperform | Get Alert |
| 10/17/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 12.32% | Wells Fargo | Connor Siversky | $33 → $34 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | — | Exane BNP Paribas | Nate Crossett | — | Initiates | → Neutral | Get Alert |
| 10/10/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 18.93% | B of A Securities | Joshua Dennerlein | → $36 | Upgrade | Neutral → Buy | Get Alert |
| 10/03/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 12.32% | Wedbush | Richard Anderson | → $34 | Initiates | → Neutral | Get Alert |
| 09/27/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 12.32% | Truist Securities | Michael Lewis | $33 → $34 | Maintains | Hold | Get Alert |
| 09/20/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 18.93% | Raymond James | Jonathan Hughes | $33 → $36 | Maintains | Outperform | Get Alert |
| 09/12/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 9.02% | RBC Capital | Michael Carroll | → $33 | Initiates | → Sector Perform | Get Alert |
| 09/08/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 15.63% | Mizuho | Haendel St. Juste | $31 → $35 | Upgrade | Neutral → Buy | Get Alert |
| 08/07/2023 | OHI | Buy Now | Omega Healthcare Invts | $30.27 | 9.02% | Wells Fargo | Connor Siversky | $32 → $33 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Omega Healthcare Invts (OHI)?
The latest price target for Omega Healthcare Invts (NYSE: OHI) was reported by Truist Securities on April 2, 2024. The analyst firm set a price target for $32.00 expecting OHI to rise to within 12 months (a possible 5.72% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Omega Healthcare Invts (OHI)?
The latest analyst rating for Omega Healthcare Invts (NYSE: OHI) was provided by Truist Securities, and Omega Healthcare Invts maintained their hold rating.
When was the last upgrade for Omega Healthcare Invts (OHI)?
The last upgrade for Omega Healthcare Investors Inc happened on March 22, 2024 when Citigroup raised their price target to $35. Citigroup previously had a neutral for Omega Healthcare Investors Inc.
When was the last downgrade for Omega Healthcare Invts (OHI)?
The last downgrade for Omega Healthcare Investors Inc happened on January 16, 2024 when B of A Securities changed their price target from $33 to $31 for Omega Healthcare Investors Inc.
When is the next analyst rating going to be posted or updated for Omega Healthcare Invts (OHI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omega Healthcare Invts, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omega Healthcare Invts was filed on April 2, 2024 so you should expect the next rating to be made available sometime around April 2, 2025.
Is the Analyst Rating Omega Healthcare Invts (OHI) correct?
While ratings are subjective and will change, the latest Omega Healthcare Invts (OHI) rating was a maintained with a price target of $31.00 to $32.00. The current price Omega Healthcare Invts (OHI) is trading at is $30.27, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.